SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-091181
Filing Date
2021-07-12
Accepted
2021-07-12 16:24:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2121701-1_424b5.htm 424B5 456716
2 GRAPHIC lg_celldextherapeutics-4c.jpg GRAPHIC 204822
  Complete submission text file 0001104659-21-091181.txt   740162
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249917 | Film No.: 211085766
SIC: 2835 In Vitro & In Vivo Diagnostic Substances